Evidence map›Paper›PMID 37867582›Full record

ArticleCase reports in infectious diseases2023

Carbapenem-Resistant

Yvonne Ayerki Nartey, Augustine Boakye Donkor, Ampem Darko Jnr Siaw, Oluwayemisi Esther Ekor, Bashiru Babatunde Jimah

Registry-linked trialOpen access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06440304 (Therapeutic Strategies for Carbapenem-Resistant Acinetobacter Baumannii Infections), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 74% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06440304 phase4recruitingnot on this mapstarted 2025, after this paper: background citation

Therapeutic Strategies for Carbapenem-Resistant Acinetobacter Baumannii Infections: Study Protocol

TypeinterventionalSponsorClinical Hospital Centre ZagrebRan2025 to 2027Enrolled108ConditionsInfections, Bacterial, Sepsis BacterialArmsFosfomycin, Eravacycline, ampicillin/sulbactam
3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yvonne Ayerki NarteyDepartment of Medicine, Cape Coast Teaching Hospital, Cape Coast, Ghana.ORCID https://orcid.org/0000-0003-2891-3082
Augustine Boakye DonkorDepartment of Clinical Microbiology, Cape Coast Teaching Hospital, Cape Coast, Ghana.ORCID https://orcid.org/0000-0002-2761-4278
Ampem Darko Jnr SiawDepartment of Medicine, Cape Coast Teaching Hospital, Cape Coast, Ghana.
Oluwayemisi Esther EkorDepartment of Anaesthesia and Pain Management, School of Medical Sciences, University of Cape Coast, Cape Coast, Ghana.
Bashiru Babatunde JimahDepartment of Medical Imaging, School of Medical Sciences, University of Cape Coast, Cape Coast, Ghana.ORCID https://orcid.org/0000-0002-6101-6546
University of Cape Coast · GH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenem-resistant

Identifiers

PMID37867582
PMCPMC10586909
OpenAlexW4387568682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.